Understanding the Key to Targeting the IGF Axis in Cancer: A Biomarker Assessment

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2015.00142
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Variants in the GH-IGF Axis Confer Susceptibilityto Lung Cancer

Genome Research
Genetics
2006English

Targeting the CCL2-CCR2 Signaling Axis in Cancer Metastasis

Oncotarget
Oncology
2016English

Targeting the Ron-Dek Signaling Axis in Breast Cancer

2013English

Targeting HER2+ Breast Cancer: The TBK1/IKK-Epsilon Axis

Oncoscience
Cancer ResearchOncology
2014English

The Therapeutic Potential of Targeting the HGF/cMET Axis in Ovarian Cancer

Molecular Diagnosis and Therapy
MedicineMolecular MedicineGeneticsPharmacology
2016English

Erratum To: Targeting the PELP1-KDM1 Axis as a Potential Therapeutic Strategy for Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2012English

The PREX1/Rac Signaling Axis: Potential as a Biomarker and Therapeutic Target in Breast Cancer

Molecular and Cellular Oncology
Cancer ResearchMolecular Medicine
2015English

Carcinoembryonic Antigen Is the Preferred Biomarker for in Vivo Colorectal Cancer Targeting

British Journal of Cancer
Cancer ResearchOncology
2013English

Prostate Cancer Characteristics Associated With Response to Pre-Receptor Targeting of the Androgen Axis

PLoS ONE
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy